TScan Therapeutics, Inc. (TCRX)

1.02 0.00 (0.00%) USD  |  NASDAQ  |  Feb 19, 16:00
1.03 +0.01 (+0.98%) After-Hours: 20:00
More

TScan Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for TCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Sutro Biopharma, Inc. Upgrade
Geron Corp. Upgrade
SELLAS Life Sciences Group, Inc. Upgrade
Agios Pharmaceuticals, Inc. Upgrade